On Thursday, groups in the Northeast, including New York City, unveiled the Joint Public Health Coalition, aimed at collaborating on evidence-based public health measures, particularly concerning vaccines. This move is seen as a direct response to the Trump administration’s approach to federal vaccine policies.
This initiative is yet another instance of how vaccine policy is diverging along political lines, as states with Democratic leadership strive to shield their residents from the ramifications of a more aggressive federal stance on vaccines.
The coalition includes Connecticut, Maine, Massachusetts, New Jersey, New York, Pennsylvania, Rhode Island, and New York City.
They are collectively recommending that infants and toddlers aged six to 23 months, as well as adults over 19, receive the latest coronavirus vaccine. Additionally, they noted that healthy children and adolescents aged 2 to 18 may receive the Covid vaccine if their parents choose it.
The collaboration has been underway since the start of this year, although representatives from each state’s Department of Health met in Rhode Island last month to finalize details.
The objective of this effort is to build on existing public health strategies among the states and aim to “protect the health, safety, and well-being of all residents,” according to the group’s statement.
In a similar vein, the Western Province coalition made vaccine recommendations on Wednesday in preparation for the upcoming winter respiratory virus season.
The West Coast Health Alliance, which includes California, Oregon, Washington, and Hawaii, has advised that all residents over six months receive the flu vaccine this fall. They have also recommended the Covid-19 vaccine for all children and pregnant women aged six months to two years.
Furthermore, the coalition suggested administering the RSV vaccine to infants under eight months and to adults aged 75 and older.
These recommendations align closely with those from prominent healthcare organizations like the American Academy of Pediatrics (AAP), the American Academy of Obstetricians and Gynecology (ACOG), and the American Academy of Family Physicians (AAFP).
However, they stand in contrast to the guidance provided by the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC).
Currently, the federal health authorities have not made any changes to their recommendations regarding the flu or RSV vaccines.
The Western Province’s recommendations come just ahead of the CDC’s Advisory Committee on Immunization Practices (ACIP), which is scheduled for a significant two-day meeting focused on vaccination protocols.
Typically, following FDA approval of a vaccine, ACIP makes recommendations on who should receive it. The Affordable Care Act mandates that insurers cover vaccines endorsed by ACIP.
Nonetheless, the reliability of the committee has faced scrutiny from health professionals and Senator Bill Cassidy (R-La.), who has openly questioned vaccine safety, especially after Health Secretary Robert F. Kennedy Jr. replaced all 17 previous members with his own selections.
The recommendations were formulated after consultation with a subject matter expert by a state health officer, who stated that guidelines were reviewed in conjunction with national healthcare organizations.
Prior to Kennedy’s appointment, leading healthcare providers usually aligned with federal recommendations and attended meetings to discuss vaccination guidelines. After the overhaul of ACIP, the group opted to establish independent recommendations, with the AAP choosing to abstain from what they deemed “illegal” ACIP meetings this summer.
Meanwhile, California Governor Gavin Newsom (D) enacted a law mandating that insurance plans cover vaccines recommended by the state. It remains unclear if other state insurance providers will adhere to state guidelines for vaccinations outside of federal recommendations.
Most major insurers have indicated that they will cover all vaccinations recommended by ACIP without cost-sharing for patients until the end of 2026, which includes updated versions of the Covid-19 and flu vaccines as of September 1.
